Biological and clinical significance of cathepsin D in breast cancer metastasis

Stem Cells

Volumn 14, Issue 6, 1996, Pages 642-650

  Garcia, Marcel ^a   Platet, Nadine ^a   Liaudet, Emmanuelle ^a   Laurent, Valérie ^a   Derocq, Danielle ^a   Brouillet, Jean Paul ^a   Rochefort, Henri ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Breast cancer; Cathepsin D; Growth inhibitors; Metastasis; Phagocytosis; Prognosis

Indexed keywords

CATHEPSIN D; ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR; PROTEIN PRECURSOR;

AMINO ACID SEQUENCE; BASEMENT MEMBRANE; BREAST CANCER; CHROMOSOME 11P; ENDOSOME; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; MITOGENESIS; NONHUMAN; NUDE MOUSE; PHAGOCYTOSIS; PHAGOSOME; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW;

MUS MUSCULUS;

EID: 0029838059     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140642     Document Type: Review

References (63)

1. Barrett AJ. Cathepsin D: purification of isoenzymes from human and chicken liver. Biochem J 1970;117:601-607.
2. Van Noort JM, Van der Drift AC. The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem 1989;264:14159-14164.
3. Mizuochi T, Yee ST, Kasai M et al. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol Lett 1994;43:189-193.
4. Saftig P, Hetman M, Schmahl W et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 1995;14:3599-3608.
5. Authier F, Mort JS, Bell AW et al. Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D. J Biol Chem 1995;270:15798-15807.
6. Krieger TJ, Hook VYH. Purification and characterization of a cathepsin D protease from bovine chromaffin granules. Biochemistry 1992;31:4223-4231.
7. Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 1989;264:13403-13406.
8. Cataldo AM, Barnett JL, Berman SA et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early upregulation of the endosomal-lysosomal system. Neuron 1995;14:671-680.
9. Keyszer GM, Heer AH, Kriegsmann J et al. Comparative analysis of cathepsin L, cathepsin D and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. Arthritis Rheum 1995;38:976-984.
10. Rochefort H, Capony F, Garcia M et al. Estrogen-induced lysosomal proteases secreted by breast cancer cells. A role in carcinogenesis? J Cell Biochem 1987;35:17-29.
11. Redecker B, Heckendorf B, Grosch HW et al. Molecular organization of the human cathepsin D gene. DNA and Cell Biol 1991;10:423-431.
12. Augereau P, Garcia M, Mattei MG et al. Cloning and sequencing of the 52K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol 1988;2:186-192.
13. Davies DR. The structure and function of the aspartic proteinases. Ann Rev Biophys Chem 1990;19:189-215.
14. Von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Ann Rev Biochem 1986;55:167-193.
15. Kornfeld S. Structure and function of the mannose-6-phosphate/insulin like growth factor II receptors. Ann Rev Biochem 1992;61:307-330.
16. Ludwig T, Munier-Lehmann H, Bauer U et al. Differential sorting of lysosomal enzymes in mannose-6-phosphate receptor-deficient fibroblasts. EMBO J 1994;13:3430-3437.
17. Capony F, Rougeot C, Montcourrier P et al. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 1989;49:3904-3909.
18. Rochefort H, Cavaillès V, Augereau P et al. Overexpression and hormonal regulation of procathepsin D in mammary and endometrial cancer. J Steroid Biochem 1989;34:177-182.
19. Cavaillès V, Garcia M, Rochefort H. Regulation of cathepsin D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 1989;3:552-558.
20. Roger P, Montcourrier P, Maudelonde T et al. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Correlation with cytosolic assay. Human Path 1994;25:863-871.
21. Escot C, Zhao Y, Puech C et al. Cellular localisation by in situ hybridization of cathepsin D, stromelysin 3 and urokinase plasminogen activator RNAs in breast cancer. Br Cancer Res Treat 1996;38:217-226.
22. Cavaillès V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 1993;90:203-207.
23. Augereau P, Mirallès F, Cavaillès V et al. Characterization of the proximal estrogen responsive element of human cathepsin D gene. Mol Endocrinol 1994;8:693-703.
24. Rio MC, Bellocq JP, Daniel JY et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal mucosa. Science 1988;241:705-708.
25. Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978;248:6351-6353.
26. Gudas J, Nguyen HLT, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995;55:4561-4565.
27. Faust PL, Kornfeld S, Chirgwin JM. Cloning and sequence analysis of cDNA for human cathepsin D. Proc Natl Acad Sci USA 1985;82:4910-4914.
28. Touitou I, Capony F, Brouillet JP et al. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction-single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer 1994;30:390-394.
29. Capony F, Morisset M, Barrett AJ et al. Phosphorylation, glycosylation and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J Cell Biol 1987;104:253-262.
30. Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem 1989;40:31-41.
31. r 52.000 cathepsin D secreted by breast cancer cells. Cancer Res 1988;48:3688-3692.
32. Westley B, May FEB, Brown AMC et al. Effects of antiestrogens on the estrogen-regulated pS2 RNA, and the 52-k and 160-kilodalton proteins in MCF7 cells and two tamoxifen resistant sublines. J Biol Chem 1984; 259:10030-10035.
33. Coopman P, Garcia M, Brunner N et al. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast cancer cells. Int J Cancer 1994;56:295-300.
34. Mathieu M, Vignon F, Capony F et al. Estradiol down regulates the mannose-6-phosphate/IGFII receptor gene and induces cathepsin D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol Endocrinol 1991;5:815-822.
35. Diment S, Leech MS, Stahl PD. Cathepsin D is membrane-associated in macrophage endosomes. J Biol Chem 1988;263:6901-6907.
36. Rijnboutt S, Aerts HMFG, Geuze HJ et al. Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J Biol Chem 1991;266:4862-4868.
37. Capony F, Braulke T, Rougeot C et al. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp Cell Res 1994;215:154-163.
38. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer 1992;28A:1780-1783.
39. Kute TE, Shao ZM, Sugg NK et al. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 1992;52:5198-5203.
40. Cardiff RD. Cathepsin D and breast cancer: useful? Hum Pathol 1994;25:847-848.
41. Westley BR, May FEB. Cathepsin D and breast cancer. Eur J Cancer 1996;32A:15-24.
42. Foekens JA, Peters HA, Look MP et al. The prognostic value of the urokinase system (uPA/uPAR/PAI-1/PAI-2) and cathepsin D in primary and recurrent breast cancer. AACR Special Conference on "Proteases and Protease Inhibitors", Panama City Beach, Florida, USA, March 1-5, 1996.
43. Podhajcer OL, Bover L, Bravo AI et al. Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J Invest Dermatol 1995;104:340-344.
44. Brouillet JP, Hanslick B, Maudelonde T et al. Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer. Clin Biochem 1991;24:491-496.
45. Tumminello FM, Gebbia N, Pizzolanti G et al. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: a preliminary report. Oncology 1995;52:237-242.
46. Ross JS, Nazeer T, Figge HL et al. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status. Am J Clin Path 1995;104:36-41.
47. r 52,000 cathepsin-D and poor prognosis in primary human breast cancer. Cancer Res 1989;49:6008-6014.
48. Garcia D, Derocq D, Pujol Pet al. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 1990;5:1809-1814.
49. Liaudet E, Garcia M, Rochefort H. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 1994;9:1145-1154.
50. Brouillet JP, Spyratos F, Hacene K et al. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. Eur J Cancer 1993;29A:1248-1251.
51. Baass PC, Di Guglielmo M, Authier F et al. Compartmentalized signal transduction by receptor tyrosine kinases. Trends Cell Biol 1995;5:465-470.
52. Montcourrier P, Mangeat P, Salazar G et al. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 1990;50:6045-6054.
53. Montcourrier P, Mangeat P, Valembois C et al. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Science 1994;107:2381-2391.
54. Spivak JL. Phagocytic tumour cells. Scand J Hematol 1973;11:253-256.
55. Van Peteghem MC, Mareel MM, De Bruyne GK. Phagocytic capacity of invasive malignant cells in the three-dimensional culture. Virchows Arch B Cell Path 1980;55:167-193.
56. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-336.
57. Lenarcic B, Kos J, Dolens I. Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochem Biophys Res Commun 1988;154:765-772.
58. Vignon F, Capony F, Chambon M et al. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52k protein. Endocrinology 1986;118:1537-1545.
59. Stewart AJ, Piggott NH, May FEB et al. Mitogenic activity of procathepsin D purified for conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer 1994;57:715-718.
60. Liaudet E, Derocq D, Rochefort H et al. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Diff 1995;6:1045-1052.
61. Chambers AF, MacDonald IC, Schmidt EE et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Met Review 1995;14:279-301.
62. Conover CA, Perry JE, Tindall DJ. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab 1995;80:987-992.
63. Briozzo P, Badet J, Capony F et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 1991;194:252-259.